Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ETRACS Internet IPO EIPO



NYSE:EIPO - Post by User

Bullboard Posts
Next >>
Post by nopooon Feb 24, 2016 8:12am
101 Views
Post# 24588362

Imagin Medical

Imagin Medical
Imagin Medical The Next Generation Ultrasensitive Imaging Solutions for Early Detection and Treatment of Cancer.....Imagin Medical Inc. is a medical imaging company positioned to radically improve the way physicians detect cancer through the use of endoscopes. The Company is developing the i/Blue Imaging System which they believe will help reduce the recurrence of bladder cancer. This technology will increase urologists ability to remove all cancerous cells through an endoscope (cystoscope) by dramatically improving the ability to visualize suspicious masses. Imagins systems unique combination of optical/laser technologies projects white light and near-infrared fluorescence through the scope to increase the imaging sensitivity, greatly reduce the dosage of chemical agents and blend the images so that only one monitor is required during surgery. The i/Blue Imaging System can be seamlessly adapted to most endoscope on the market today......The companys products are based on the invention of Dr. Stavros Demos from the Lawrence Livermore National Laboratory (LLNL). Dr. Stavros worked in collaboration with the UC Davis Comprehensive Cancer Center and Dr. Ralph deVere White, one of the worlds leading authorities on bladder cancer, for more than five years to prove feasibility. IME has entered into a partnership with the LLNL and UC Davis to complete additional clinical evaluations that will support their FDA submission.
Bullboard Posts
Next >>